Convergence Investment Partners’s Hologic HOLX Stock Holding History

Convergence Investment Partners’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,648	Closed	-$253K	–	223
2022 Q2	$253K	Sell	3,648 -138	-4%	-$10.2K	0.15%	137
2022 Q1	$291K	Sell	3,786 -56	-1%	-$4.03K	0.15%	140
2021 Q4	$294K	Buy	+3,842	New	+$282K	0.15%	142
2021 Q2	–	Sell	-4,085	Closed	-$304K	–	260
2021 Q1	$304K	Buy	4,085 +805	+25%	+$61.1K	0.14%	151
2020 Q4	$239K	Sell	3,280 -11,878	-78%	-$838K	0.12%	157
2020 Q3	$1.01M	Buy	+15,158	New	+$959K	0.35%	106
2018 Q2	–	Sell	-105	Closed	-$4K	–	569
2018 Q1	$4K	Buy	+105	New	+$4.24K	﹤0.01%	874
2015 Q4	–	Sell	-113,640	Closed	-$4.45M	–	354
2015 Q3	$4.45M	Buy	+113,640	New	+$4.51M	0.51%	56

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Convergence Investment Partners's HOLX Position: Q3 2022 in Review

Convergence Investment Partners sold out of Hologic (HOLX) in Q3 2022, closing a stake of 3,648 shares — an estimated $253K sold.

Convergence Investment Partners first reported a position in HOLX in Q3 2015 and held it in 8 quarters. The position peaked at $4.45M in Q3 2015. 654 funds tracked by Wall St. Rank hold HOLX as of Q3 2022.

Convergence Investment Partners reported no remaining Hologic position as of Q3 2022 after selling out during the quarter.
Convergence Investment Partners sold 3,648 Hologic shares in Q3 2022, an estimated $253K.
Convergence Investment Partners first reported a position in Hologic in Q3 2015 and held it in 8 quarters.
Convergence Investment Partners's Hologic position peaked at $4.45M in Q3 2015.
654 funds tracked by Wall St. Rank held Hologic as of Q3 2022.

Based on Convergence Investment Partners's 13F filing for Q3 2022, filed 8 Nov 2022.